Business
Covered entities include hospitals that serve a disproportionate share of financially needy patients, community health clinics, and other entities that receive certain types of grants under the Public Health Service Act.
HARROW, INC.: Revenue grew 36.4% to $272M from $200M. Net loss narrowed to $5.139M from $17.48M. Free cash flow turned positive at $42.98M from a $23.8M outflow. Operating margin expanded 679 bps to 11.21%. HARROW, INC.'s principal statistical and annual-change screens add no overriding warning to the reported profit and cash-flow record.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 36.4% to $272M from $200MOK
- Profitability — Net loss narrowed to $5.139M from $17.48MOK
- Cash flow — Free cash flow turned positive at $42.98M from a $23.8M outflowOK
- Margins — Operating margin expanded 679 bps to 11.21%OK
- Accounting — No overriding statistical warningNote
- Insiders — 4 purchases and 4 salesOK
Where the revenue comes from
Fiscal 2025, as HARROW, INC. reports it. History and quarterly detail are in the app.
- Branded$195.8M
- Imprimis Rx$76.5M
Leadership changes
From HARROW, INC.'s own filings, the day they're filed.
- Randall E. Pollard · Chief Accounting Officer · appointmenteff. 2025-08-21
- Andrew R. Boll · President · appointmenteff. 2025-08-21
- Marty A. Makary · Directors · departureeff. 2025-01-17
Latest filings
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-08-10
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-22
- 8-K · Company announcement2026-06-03
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about HARROW, INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.